Using in vitro, together with in vivo experiments, we evaluated the therapeutic impact of the siFoxM1-Apt-CNBs combined with UMND transfection therapy and the expression of FoxM1 and E-cadherin in LNCaP cells and xenografts tumor in nude mice. This evidence concerns the gene CDH1 and neoplasm.